Cargando…

Reactive oxygen metabolites can be used to differentiate malignant and non-malignant pleural efffusions

OBJECTIVE: Increase in reactive oxygen metabolites (ROM) and free radicals is an important cause of cell injury. In this study, we investigated whether determination of ROM in pleural fluids of patients with malignant and non-malignant pleural effusions can be used as a tumor marker indicating malig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cobanoglu, Ufuk, Sayir, Fuat, Mergan, Duygu
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930651/ https://www.ncbi.nlm.nih.gov/pubmed/20835307 http://dx.doi.org/10.4103/1817-1737.65042

Ejemplares similares

A novel approach for preventing recurrence of malign pleural effusion: early phase pleurodesis
por: Cobanoglu, Ufuk, et al.
Publicado: (2018)

Late complications due to thoracic traumas
por: İliklerden, Duygu Mergan, et al.
Publicado: (2022)

Surgery for bronchiectasis: The effect of morphological types to prognosis
por: Cobanoglu, Ufuk, et al.
Publicado: (2011)

Are Serum Mac 2-Binding Protein Levels Elevated in Esophageal Cancer? A Control Study of Esophageal Squamous Cell Carcinoma Patients
por: Cobanoglu, Ufuk, et al.
Publicado: (2018)

The use of Ligasure Vessel Sealing System in Ivor Lewis esophagectomy
por: Sayir, Fuat, et al.
Publicado: (2012)

Comparison of the methods of fibrinolysis by tube thoracostomy and thoracoscopic decortication in children with stage II and III empyema: a prospective randomized study
por: Cobanoglu, Ufuk, et al.
Publicado: (2011)

A long-term study assessing the factors influencing survival and morbidity in the surgical management of bronchiectasis
por: Sehitogullari, Abidin, et al.
Publicado: (2011)

Malignant pleural effusions: Differentiating pelvic malignancies
por: Sharma, Mukesh, et al.
Publicado: (2015)

Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions
por: Korczynski, P, et al.
Publicado: (2009)

Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions
por: JI, QIAOYING, et al.
Publicado: (2014)

Novel clinical radiomic nomogram method for differentiating malignant from non-malignant pleural effusions
por: Han, Rui, et al.
Publicado: (2023)

Diffusion-Weighted Imaging Can Differentiate between Malignant and Benign Pleural Diseases
por: Usuda, Katsuo, et al.
Publicado: (2019)

Detection of reactive oxygen metabolites in malignant and adjacent normal tissues of patients with lung cancer
por: Okur, Hacer Kuzu, et al.
Publicado: (2013)

Pleural amyloidosis imitating pleural malignancy
por: Coolbear, Frith, et al.
Publicado: (2017)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Comparative Analysis of Mean Pleural Fluid D-dimer Level in Malignant and Non-Malignant Pleural Effusion Patients
por: Emami Ardestani, Mohammad, et al.
Publicado: (2019)

The role of LENT and PROMISE scores in predicting survival in malignant pleural effusion
por: Ermin, Sinem, et al.
Publicado: (2022)

Multiple distant metastases in a case of malignant pleural mesothelioma
por: Tertemiz, Kemal Can, et al.
Publicado: (2014)

Score for Differentiating Pleural Tuberculosis from Malignant Effusion
por: González, Alejandra, et al.
Publicado: (2019)

Clinical value of combined detection of reactive oxygen species modulator 1 and adenosine deaminase in pleural effusion in the identification of NSCLC associated malignant pleural effusion
por: Zhang, Fan, et al.
Publicado: (2019)

The investigation of the volatile metabolites of lung cancer from the microenvironment of malignant pleural effusion
por: Chen, Ke-Cheng, et al.
Publicado: (2021)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Computed Tomography and Spirometry Can Predict Unresectability in Malignant Pleural Mesothelioma
por: Bellini, Alice, et al.
Publicado: (2021)

Level of mesothelin expression can indicate the prognosis of malignant pleural mesothelioma
por: Feng, Feifei, et al.
Publicado: (2020)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Management of Malignant Pleural Effusions
por: Villanueva, Andrew G.
Publicado: (2012)

Management of Malignant Pleural Effusions
por: Charpidou, Adrianni, et al.
Publicado: (2006)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Advances in pleural infection and malignancy
por: Bedawi, Eihab O., et al.
Publicado: (2021)

Malignant pleural mesothelioma in situ
por: Ando, Kohei, et al.
Publicado: (2022)

Diagnostic Value and Prognostic Significance of Pleural C-Reactive Protein in Lung Cancer Patients with Malignant Pleural Effusions
por: Park, Do-Sim, et al.
Publicado: (2013)

Erratum to: Evaluation of gene expression levels in the diagnosis of lung adenocarcinoma and malignant pleural mesothelioma
por: Ömeroğlu Şimşek, Gökçen, et al.
Publicado: (2022)

Management of malignant pleural effusion with different pleural catheters
por: Karapolat, Sami, et al.
Publicado: (2018)

Multidetector CT Findings and Differential Diagnoses of Malignant Pleural Mesothelioma and Metastatic Pleural Diseases in Korea
por: Kim, Yoon Kyung, et al.
Publicado: (2016)

Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion
por: Chen, Kuan-Yuan, et al.
Publicado: (2016)

Differentiation of malignant from benign pleural effusions based on artificial intelligence
por: Wang, Sufei, et al.
Publicado: (2023)

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Implantation of permanent pleural catheter for palliation of malignant pleural effusion
por: Meier, Michelle, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_clbugc51ud51hq830g037fdmj7